Please login to the form below
priority access
This page shows the latest priority access news and features for those working in and with pharma, biotech and healthcare.
WHO advises both doses of Pfizer/BioNTech’s COVID-19 vaccine within a 21-28 day schedule
The WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) added, however, that countries should be able to administer the two doses over six weeks to ensure more high-priority ... groups can access the vaccine.
Latest news
-
Abivax’s COVID-19 study declared Research National Priority by French government
Those clinical trials, including Abivax’s study, that are declared to be a national priority gain access to an accelerated regulatory review and approval process by the French regulatory authorities (ASNM) ... AGE trial with ABX464 drug candidate a
-
WHO says 172 countries are poised to participate in COVID-19 vaccine initiative
It is the only global initiative working with governments and manufacturers to ensure equitable access to COVID-19 vaccines. ... vulnerability, with front-line health and social care workers to be given priority.
-
The NHS is facing shortages of lifesaving treatments, says internal document
The document also apparently told doctors that certain patients would need to have priority over others for access to lifesaving drugs. Recommendations for rationing in the document included breaking tablets in ... You may wish to consider the following
-
NHS England says yes to Roche's Hemlibra
which has ensured access to emicizumab for patients with inhibitors with limited treatment options.”. ... Hemlibra's market access was agreed outside the normal framework of NHS England's specialised commissioning, which ranks treatments and procedures
-
Amgen gets prevention claim for cholesterol drug Repatha
Amgen CEO Robert Bradway said a few weeks ago that “improving patient access to Repatha remains a top priority for our team”, adding that the cardiovascular outcomes data will be a ... With this approval, it's now more important than ever that
Abivax’s COVID-19 study declared Research National Priority by French government
WHO says 172 countries are poised to participate in COVID-19 vaccine initiative
The NHS is facing shortages of lifesaving treatments, says internal document
NHS England says yes to Roche's Hemlibra
Amgen gets prevention claim for cholesterol drug Repatha
More from news
Approximately 1 fully matching, plus 15 partially matching documents found.
Latest Intelligence
-
Building BRICs: pharma's key emerging markets are becoming giants
Further, the inference that locally-produced drugs may gain preferential access to state reimbursement lists has provided an added incentive for international manufacturers to invest in Russian infrastructure. ... Improving access to healthcare remains a
Building BRICs: pharma's key emerging markets are becoming giants
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Events Executive
-
Depending on Experience
-
Digital account director
-
Competitive
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Understanding the ‘real world’ starts and ends with the patient
- AZ publishes new real-world safety data for COVID-19 vaccine Vaxzevria
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- Sanofi raises profit forecast following positive Q2 results
- Biogen/Eisai push for second approval in Alzheimer’s disease
- Reducing primary care antibiotic use may not be enough to counter antimicrobial resistance
- SoftBank buys $5bn stake in Roche
- Live Webinar: Making Wearable Technology Scalable and Adoptable
- Live Webinar: Transforming the Future of Health & Aging from a Global Health & Social Impact Approach
- Investors respond positively to “strong” Eli Lilly results
- Amanda Pritchard becomes NHS England’s first female chief executive
- Biogen/Eisai push for second approval in Alzheimer’s disease
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- Understanding the ‘real world’ starts and ends with the patient
- BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform
- Amgen pays $900m upfront to acquire Teneobio’s antibody assets, R&D technologies
PMHub
Mind+Matter
We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...
Latest intelligence
- Ask the writers: Transitioning from academia to medical writing
- Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
- Strategic launch planning: familiar framework, new mindset
- By James Aird...
- Guide
- How to embrace behavioural science principles in healthcare MR...
